Aevice Health, a Singapore-based medtech company specialising in developing remote respiratory monitoring solutions, has received approval from the Health Sciences Authority of Singapore (HSA) for its flagship medical device, the AeviceMD Monitoring System.
spacezerocom Shutterstock
403222441
Box tick symbolising approval
The award-winning patient management platform, powered by a smart wearable stethoscope, is the first of its kind to be made available in Singapore.
The AeviceMD Monitoring System’s wearable stethoscope is one of the smallest globally that can detect abnormal breath sounds, such as wheezing, and monitor vital signs including heart rate and respiratory rate. The device, approved for use in patients three years and above, has a form factor that allows for continuous and comfortable monitoring across ages from young children to the elderly, where respiratory diseases are more prevalent.
Chronic respiratory disease affects over 545 million people worldwide and is one of the leading causes of mortality. Asthma and COPD (Chronic Obstructive Pulmonary Disease), which are prevalent in Singapore and many other countries, contribute significantly to hospital emergency department (ED) visits and readmissions. Early detection of exacerbations can prevent many of these hospitalisations.
The AeviceMD Monitoring System continuously monitors digital biomarkers of interest, providing healthcare professionals with an overview of the patient's lung health to track progress over time. Patients, who are at risk of exacerbations, can be identified early to prevent readmissions or ED visits.
Adrian Ang, chief executive officer of Aevice Health, said: "This is a momentous milestone for the company and a timely achievement as our pipeline of partnerships in Singapore grows. We are excited to leverage Singapore's strategic presence in Asia as a medical hub to bring this novel technology into new markets where there is a high prevalence of respiratory diseases."
With the approval of the AeviceMD Monitoring System, Aevice Health is well- positioned to expand its reach and provide much-needed respiratory monitoring solutions to patients in Singapore and beyond.
